Correlation Between CSP and Inhibrx Biosciences,
Can any of the company-specific risk be diversified away by investing in both CSP and Inhibrx Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSP and Inhibrx Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSP Inc and Inhibrx Biosciences,, you can compare the effects of market volatilities on CSP and Inhibrx Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSP with a short position of Inhibrx Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSP and Inhibrx Biosciences,.
Diversification Opportunities for CSP and Inhibrx Biosciences,
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between CSP and Inhibrx is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding CSP Inc and Inhibrx Biosciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx Biosciences, and CSP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSP Inc are associated (or correlated) with Inhibrx Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx Biosciences, has no effect on the direction of CSP i.e., CSP and Inhibrx Biosciences, go up and down completely randomly.
Pair Corralation between CSP and Inhibrx Biosciences,
Given the investment horizon of 90 days CSP Inc is expected to under-perform the Inhibrx Biosciences,. But the stock apears to be less risky and, when comparing its historical volatility, CSP Inc is 1.04 times less risky than Inhibrx Biosciences,. The stock trades about -0.16 of its potential returns per unit of risk. The Inhibrx Biosciences, is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 1,244 in Inhibrx Biosciences, on May 6, 2025 and sell it today you would earn a total of 936.00 from holding Inhibrx Biosciences, or generate 75.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
CSP Inc vs. Inhibrx Biosciences,
Performance |
Timeline |
CSP Inc |
Inhibrx Biosciences, |
CSP and Inhibrx Biosciences, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CSP and Inhibrx Biosciences,
The main advantage of trading using opposite CSP and Inhibrx Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSP position performs unexpectedly, Inhibrx Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx Biosciences, will offset losses from the drop in Inhibrx Biosciences,'s long position.The idea behind CSP Inc and Inhibrx Biosciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Inhibrx Biosciences, vs. Keros Therapeutics | Inhibrx Biosciences, vs. Janux Therapeutics | Inhibrx Biosciences, vs. Fennec Pharmaceuticals | Inhibrx Biosciences, vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |